Synapse Open Synapse
Biology

Hype vs. reality: What pharma’s hottest R&D bets have actually proved

BioPharma Dive · · 8 min read

New types of bispecifics, antibody-drug conjugates and cell therapies haven’t yet proven themselves in the clinic. Pharmaceutical companies are betting billions anyway.

Latest from BioPharma Dive